ArticleJournal of clinical epidemiology2012

Should risky treatments be reserved for secondary prevention? Theoretical considerations regarding risk-benefit tradeoffs.

M Brandon Westover et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.